Follow the EyePoint, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €446m. The latest transaction was disclosed on 24 August 2026 (J). Among the most active insiders: Elston George. Every trade is free.
29
Insider Decl.
n/a
Thresholds
€62,352
2 ops.
Buy Volume
€838,646
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate EyePoint, Inc. Buy (bullish), based on 11 analysts. Average price target: US$27.36.
38Σ signal
Buys €62,352€838,646 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,031 of 29,062 companies
25.8
score / 100
Value
3
Quality
49
FCF yld-65%
Earn yld-62%
EV/EBITDA·
ROE-149%
Gross mgn93%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
EyePoint, Inc. es una empresa centrada en el desarrollo de tratamientos oftálmicos innovadores. Se concentra en soluciones para enfermedades oculares graves.